April 11, 2014 Meeting Conference


Professional Practice Gaps:  

Using feedback from NEOS members and discussion by the Program Committee, retinal pharmacology was identified as a significant professional practice gap in our membership.

Program Objectives: 

The content and format of this educational activity has been specifically designed to fill the identified practice gaps in our membership's current and potential scope of professional activities in a way that focuses on education, while managing commercial support and maintaining independence from promotional activities and commercial proprietary interests. This program seeks to: 

1) Increase the competence of the audience in the areas of pharmacological management of retinal vascular disorders,including age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. 

2) Improve the performance of the audience in the management of both nonexudative and exudative age-related macular degeneration. 

3) Improve outcomes in the area of patient care of common retinal disorders.


Diabetic Macular Edema 2014: Who gets treated and with what?
Scott M. Steidl

Morning program

Pharmacotherapeutic Management of Exudative AMD II: Which Maintenance Regimen?
Elias Reichel

Morning program

AREDS 2: Did we learn anything?
Ivana K. Kim

Morning program

Compounding Pharmacies – Where Do We Stand?
Trexler M. Topping

Afternoon program

The Pharmacotherapeutic Management of Exudative AMD I: Which Drug?
Ron Adelman

Morning program

The Evoluation of Pharmacotherapy for Retinal Venous Occlusive Disease
Julia Haller

Morning program

The Vitreomacular Interface: Pharmacological Targeting
Julia Haller

Morning program

ROP: Origins of long term effects on retinal and visual function
Anne B. Fulton

Morning program